How omics is revealing new roles for glia in addiction
Glia · 2025
DOI: 10.1002/glia.24584 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Glia, 2025. Verfasst von David J Bergkamp und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Neuroglia, Substance-Related Disorders, Metabolomics, Genomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Experiments to study the biology of addiction have historically focused on the mechanisms through which drugs of abuse drive changes in the functioning of neurons and neural circuits. Glia have often been ignored in these studies, however, and this has left many questions in the field unanswered, particularly, surrounding how glia contribute to changes in synaptic plasticity, regulation of neuroinflammation, and functioning of neural ensembles given massive changes in signaling across the CNS. Omics methods (transcriptomics, translatomics, epigenomics, proteomics, metabolomics, and others) have expanded researchers' abilities to generate hypotheses and carry out mechanistic studies of glial cells during acquisition of drug taking, intoxication, withdrawal, and relapse to drug seeking. Here, we present a survey of how omics technological advances are revising our understanding of astrocytes, microglia, oligodendrocytes, and ependymal cells in addiction biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, University of Washington, Seattle, Washington, USA.
- VISN 20 Mental Illness Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington, USA.
- Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, Washington, USA.
ORCID-Profile: David J Bergkamp, John F Neumaier
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Bergkamp, D. J., & Neumaier, J. F. (2025). How omics is revealing new roles for glia in addiction. Glia. https://doi.org/10.1002/glia.24584
Vancouver
Bergkamp DJ, Neumaier JF. How omics is revealing new roles for glia in addiction. Glia. 2025. doi:10.1002/glia.24584
BibTeX
@article{Bergkamp2025,
author = {Bergkamp, David J and Neumaier, John F},
title = {How omics is revealing new roles for glia in addiction},
journal = {Glia},
year = {2025},
doi = {10.1002/glia.24584}
}
EUVIMED